ONX-0914 (PR-957)
To Order Contact us: stephen@expresspharmapulse.com
) ONX-0914 (PR-957) |
|||
| A4011-50 | ApexBio | 50 mg | EUR 569 |
|
Description: ONX-0914, previously known as PR-975, is a potent inhibitor of immunoproteasome, a form of proteasome generating peptides presented on major histocompatibility complex (MHC) class I molecule to cytotixic T cells. |
|||
ONX-0914 (PR-957) |
|||
| A4011-S | ApexBio | Evaluation Sample | EUR 81 |
|
Description: ONX-0914, previously known as PR-975, is a potent inhibitor of immunoproteasome, a form of proteasome generating peptides presented on major histocompatibility complex (MHC) class I molecule to cytotixic T cells. |
|||
 ONX-0914 |
|||
| 2555-25 | Biovision | EUR 675 | |
ONX-0914 |
|||
| 2555-5 | Biovision | EUR 207 | |
ONX-0914 |
|||
| HY-13207 | MedChemExpress | 10mM/1mL | EUR 138 |
) Oprozomib (ONX-0912) |
|||
| A1934-10 | ApexBio | 10 mg | EUR 235 |
|
Description: ONX-0912 (as known as oprozomib), discovered during a medicinal chemistry effort using tripeptide epoxyketones, is an orally bio-available and potent proteasome inhibitor that inhibits growth and induces apoptosis in bortezomib resistant multiple myeloma (MM) cells. |
|||
Oprozomib (ONX-0912) |
|||
| A1934-100 | ApexBio | 100 mg | EUR 746 |
|
Description: ONX-0912 (as known as oprozomib), discovered during a medicinal chemistry effort using tripeptide epoxyketones, is an orally bio-available and potent proteasome inhibitor that inhibits growth and induces apoptosis in bortezomib resistant multiple myeloma (MM) cells. |
|||
Oprozomib (ONX-0912) |
|||
| A1934-25 | ApexBio | 25 mg | EUR 398 |
|
Description: ONX-0912 (as known as oprozomib), discovered during a medicinal chemistry effort using tripeptide epoxyketones, is an orally bio-available and potent proteasome inhibitor that inhibits growth and induces apoptosis in bortezomib resistant multiple myeloma (MM) cells. |
|||
Oprozomib (ONX-0912) |
|||
| A1934-5 | ApexBio | 5 mg | EUR 171 |
|
Description: ONX-0912 (as known as oprozomib), discovered during a medicinal chemistry effort using tripeptide epoxyketones, is an orally bio-available and potent proteasome inhibitor that inhibits growth and induces apoptosis in bortezomib resistant multiple myeloma (MM) cells. |
|||
Oprozomib (ONX-0912) |
|||
| A1934-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 213 |
|
Description: ONX-0912 (as known as oprozomib), discovered during a medicinal chemistry effort using tripeptide epoxyketones, is an orally bio-available and potent proteasome inhibitor that inhibits growth and induces apoptosis in bortezomib resistant multiple myeloma (MM) cells. |
|||
 ACY-957 |
|||
| HY-104008 | MedChemExpress | 10mg | EUR 636 |
 Antibody) SMC1 (Ab-957) Antibody |
|||
| 21190-100ul | SAB | 100ul | EUR 252 |
SMC1 (Ab-957) Antibody |
|||
| 21190-50ul | SAB | 50ul | EUR 187 |
 Antibody) SMC1A (Ab-957) Antibody |
|||
| CSB-PA775738- | Cusabio | EUR 335 | |
|
|||
|
Description: A polyclonal antibody against SMC1A (Ab-957). Recognizes SMC1A (Ab-957) from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:1000, IHC:1:50-1:200 |
|||
SMC1A (Ab-957) Antibody |
|||
| CSB-PA775738-100ul | Cusabio | 100ul | EUR 316 |
|
|||
|
Description: A polyclonal antibody against SMC1A (Ab-957). Recognizes SMC1A (Ab-957) from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:1000, IHC:1:50-1:200 |
|||
) anti-SMC1 (Ab-957) |
|||
| LF-PA20461 | Abfrontier | 100 ul | EUR 334 |
|
Description: Rabbit polyclonal to SMC1 |
|||
 PR antibody |
|||
| 70R-13954 | Fitzgerald | 100 ug | EUR 322 |
|
Description: Affinity purified Rabbit polyclonal PR antibody |
|||
PR antibody |
|||
| 10R-1954 | Fitzgerald | 100 ul | EUR 349 |
|
Description: Mouse monoclonal PR antibody |
|||
PR antibody |
|||
| 70R-36087 | Fitzgerald | 100 ug | EUR 327 |
|
Description: Rabbit polyclonal PR antibody |
|||
PR antibody |
|||
| 70R-36593 | Fitzgerald | 100 ug | EUR 327 |
|
Description: Rabbit polyclonal PR antibody |
|||
 PR Antibody |
|||
| BF0581 | Affbiotech | 200ul | EUR 376 |
|
Description: PR antibody detects endogenous levels of total PR. |
|||
 PR-619 |
|||
| A8212-100 | ApexBio | 100 mg | EUR 374 |
|
Description: (2,6-diamino-5-thiocyanatopyridin-3-yl) thiocyanate, also designated as PR-619, is a broad-range reversible and cell-permeable inhibitor of deubiquitylating enzyme (DUB)[1][2][3], potently suppresses the activity of almost all cysteine protease DUBs[4]. |
|||
PR-619 |
|||
| A8212-25 | ApexBio | 25 mg | EUR 166 |
|
Description: (2,6-diamino-5-thiocyanatopyridin-3-yl) thiocyanate, also designated as PR-619, is a broad-range reversible and cell-permeable inhibitor of deubiquitylating enzyme (DUB)[1][2][3], potently suppresses the activity of almost all cysteine protease DUBs[4]. |
|||
PR-619 |
|||
| A8212-5 | ApexBio | 5 mg | EUR 96 |
|
Description: (2,6-diamino-5-thiocyanatopyridin-3-yl) thiocyanate, also designated as PR-619, is a broad-range reversible and cell-permeable inhibitor of deubiquitylating enzyme (DUB)[1][2][3], potently suppresses the activity of almost all cysteine protease DUBs[4]. |
|||
PR-619 |
|||
| A8212-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 142 |
|
Description: (2,6-diamino-5-thiocyanatopyridin-3-yl) thiocyanate, also designated as PR-619, is a broad-range reversible and cell-permeable inhibitor of deubiquitylating enzyme (DUB)[1][2][3], potently suppresses the activity of almost all cysteine protease DUBs[4]. |
|||
PR-619 |
|||
| A8212-S | ApexBio | Evaluation Sample | EUR 81 |
|
Description: (2,6-diamino-5-thiocyanatopyridin-3-yl) thiocyanate, also designated as PR-619, is a broad-range reversible and cell-permeable inhibitor of deubiquitylating enzyme (DUB)[1][2][3], potently suppresses the activity of almost all cysteine protease DUBs[4]. |
|||
PR-619 |
|||
| HY-13814 | MedChemExpress | 50mg | EUR 366 |
 Antibody) Histone H1(HH1/957) Antibody |
|||
| BNUM0957-50 | Biotium | 50uL | EUR 395 |
|
Description: Primary antibody against Histone H1(HH1/957), 1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNUB0957-100 | Biotium | 100uL | EUR 209 |
|
Description: Primary antibody against Histone H1(HH1/957), Concentration: 0.2mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNUB0957-500 | Biotium | 500uL | EUR 458 |
|
Description: Primary antibody against Histone H1(HH1/957), Concentration: 0.2mg/mL |
|||
 Conjugated Antibody) SMC1 (Ab-957) Conjugated Antibody |
|||
| C21190 | SAB | 100ul | EUR 397 |
Histone H1(HH1/957) Antibody |
|||
| BNC550957-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against Histone H1(HH1/957), CF555 conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNC550957-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against Histone H1(HH1/957), CF555 conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNC610957-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against Histone H1(HH1/957), CF660R conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNC610957-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against Histone H1(HH1/957), CF660R conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNC470957-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against Histone H1(HH1/957), CF647 conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNC470957-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against Histone H1(HH1/957), CF647 conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNC050957-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against Histone H1(HH1/957), CF405M conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNC050957-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against Histone H1(HH1/957), CF405M conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNC400957-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against Histone H1(HH1/957), CF640R conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNC400957-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against Histone H1(HH1/957), CF640R conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNC430957-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against Histone H1(HH1/957), CF543 conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNC430957-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against Histone H1(HH1/957), CF543 conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNC040957-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against Histone H1(HH1/957), CF405S conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNC040957-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against Histone H1(HH1/957), CF405S conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNC800957-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against Histone H1(HH1/957), CF680 conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNC800957-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against Histone H1(HH1/957), CF680 conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNCP0957-250 | Biotium | 250uL | EUR 383 |
|
Description: Primary antibody against Histone H1(HH1/957), PerCP conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNCR0957-250 | Biotium | 250uL | EUR 383 |
|
Description: Primary antibody against Histone H1(HH1/957), RPE conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNCA0957-250 | Biotium | 250uL | EUR 383 |
|
Description: Primary antibody against Histone H1(HH1/957), APC conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNCAP0957-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against Histone H1(HH1/957), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNCAP0957-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against Histone H1(HH1/957), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNCB0957-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against Histone H1(HH1/957), Biotin conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNCB0957-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against Histone H1(HH1/957), Biotin conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNCH0957-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against Histone H1(HH1/957), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNCH0957-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against Histone H1(HH1/957), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNC880957-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against Histone H1(HH1/957), CF488A conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNC880957-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against Histone H1(HH1/957), CF488A conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNC940957-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against Histone H1(HH1/957), CF594 conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNC940957-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against Histone H1(HH1/957), CF594 conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNC680957-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against Histone H1(HH1/957), CF568 conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNC680957-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against Histone H1(HH1/957), CF568 conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNC700957-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against Histone H1(HH1/957), CF770 conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNC700957-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against Histone H1(HH1/957), CF770 conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNC810957-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against Histone H1(HH1/957), CF680R conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNC810957-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against Histone H1(HH1/957), CF680R conjugate, Concentration: 0.1mg/mL |
|||
 PR Monoclonal Antibody |
|||
| 40481-100ul | SAB | 100ul | EUR 252 |
PR Monoclonal Antibody |
|||
| 40481-50ul | SAB | 50ul | EUR 187 |